Picture of Therma Bright logo

THRM Therma Bright Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-42.55%
3m-61.36%
6m-80.14%
1yr-63.29%
Volume Change (%)
10d/3m+1.7%
Price vs... (%)
52w High-91.25%
50d MA-39.55%
200d MA-70.45%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-262.42%
Return on Equity-225.21%
Operating Margin-5553.56%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Jul 202531st Jul 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Therma Bright EPS forecast chart

Profile Summary

Therma Bright Inc. is a Canada-based developer and investment partner specializing in advanced diagnostic and medical device technologies that address key healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The Company holds trademarks for Therozap, InterceptCS and AcuVid.

Directors

Last Annual
July 31st, 2024
Last Interim
April 30th, 2025
Incorporated
February 8th, 2018
Public Since
July 11th, 2001
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
ca flag iconTSX Venture Exchange
Shares in Issue
56,807,143

THRM Share Price Performance

Similar to THRM

Picture of Aurora Spine logo

Aurora Spine

ca flag iconTSX Venture Exchange

Picture of CardioComm Solutions logo

CardioComm Solutions

ca flag iconTSX Venture Exchange

Picture of Conavi Medical logo

Conavi Medical

ca flag iconTSX Venture Exchange

Picture of Covalon Technologies logo

Covalon Technologies

ca flag iconTSX Venture Exchange

Picture of EvokAI Creative Labs logo

EvokAI Creative Labs

ca flag iconTSX Venture Exchange

FAQ